Prathima Prodduturi, M.D.





Internal Medicine


Internal Medicine


  • Associate Physician Diplomate


To see if Prathima Prodduturi is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Philosophy of Care

Our mission is to provide comprehensive and compassionate care to our patients and their care givers. An affiliation with UC Davis, our patients receive access to many clinical trials and leading edge research. We make sure every patient receives the very best treatment possible by practicing the art and science of medicine.

Clinical Interests

Dr. Prodduturi is a general hematologist/oncologist offering care for patients with various blood disorders and cancers. She has special interests and experience in treating patients with breast cancer and lymphomas.


Hematology and Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center


M.B.B.S., Osmania Medical College, Hyderabad, N T R University of Health Sciences, India 2003

Internship: Internal Medicine, John H Stroger Jr. Hospital of Cook County, Chicago IL 2006-2007


Internal Medicine, University of North Dakota, Fargo ND 2007-2009


Hematology/Oncology, University of Nebraska Medical Center, Omaha NE 2009-2012

Board Certifications

American Board of Internal Medicine,

American Board of Internal Medicine, Hematology and Oncology,

CA Medical Board, License, 2018

Educational Commission For Foreign Medical Graduates (ECFMG),

Professional Memberships

American Society of Clinical Oncology

American Society of Hematology

Canadian Medical Association

Honors and Awards

Clinical Skills and Scholarship Award (Best Intern) at John H Stroger Jr. Hospital of Cook County, Chicago, 2007

Graduated top of the class in medical school, 2013

Select Recent Publications

Prodduturi P, Bierman JP. New and emerging treatments in Primary Central Nervous System Lymohoma. Clinical Medicine Insights: Oncology. 2012 May.

Prodduturi P, Perry A, Aoun P, Akhtari M. "Recurrent bone marrow aplasia secondary to nilotinib in a patient with chronic myeloid leukemia: a case report and review of the literature. Journal of Oncology Pharmacy Practice. 2012 March.

Prodduturi P, Armitage JO. Reduced Intensity Treatment in Early Stage Hodgkin Lymphoma. Blood and Lymphatic Cancer: Targets and Therapy. 2011 November.

Nathan S, Amin A, Prodduturi P. Older Age Strongly Impacts Selection for Early Invasive Therapies in Cardiogenic Shock with Differential Patterns of 1-Year Survival Observed in Younger vs. Older Patients. Circulation. 2006 May;113(e788-e834):179.